Literature DB >> 1317262

p53 Mutations in human hepatocellular carcinomas from Germany.

S Kress1, U R Jahn, A Buchmann, P Bannasch, M Schwarz.   

Abstract

Mutations in the p53 gene are frequent genetic alterations in human hepatocellular carcinomas. We have examined 13 cases of human hepatocellular carcinomas from Germany for the presence of p53 aberrations in exons 4 to 8 of the gene by single-strand conformation polymorphism and restriction fragment-length polymorphism analyses and by sequencing of polymerase chain reaction products. Single base substitutions occurred in two human hepatocellular carcinomas: a C:G----T:A transition at a CpG site in codon 257, and a T:A----A:T transversion at codon 273. One of these point-mutated tumors and two additional tumors without point mutations demonstrated a loss of one p53 allele. None of the tumors was mutated in codons 12 or 61 of the c-Ha-ras gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317262

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Effect of 5-Aza-2'-deoxycytidine on the P16 tumor suppressor gene in hepatocellular carcinoma cell line HepG2.

Authors:  L H Liu; W H Xiao; W W Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 3.  Mechanisms underlying aflatoxin-associated mutagenesis - Implications in carcinogenesis.

Authors:  Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2019-03-07

Review 4.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

5.  Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes.

Authors:  F Aguilar; S P Hussain; P Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.

Authors:  G Chemeris; A Loktinov; A Rempel; M Schwarz; P Bannasch
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Expression of mutant p53 protein in hepatocellular carcinoma.

Authors:  J D Collier; M Carpenter; A D Burt; M F Bassendine
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  Genetic heterogeneity of hepatocellular carcinoma.

Authors:  H Unsal; C Yakicier; C Marçais; M Kew; M Volkmann; H Zentgraf; K J Isselbacher; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Authors:  K A McGlynn; E A Rosvold; E D Lustbader; Y Hu; M L Clapper; T Zhou; C P Wild; X L Xia; A Baffoe-Bonnie; D Ofori-Adjei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

10.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.